{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:22:16Z","timestamp":1774362136273,"version":"3.50.1"},"reference-count":189,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["449501615"],"award-info":[{"award-number":["449501615"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Pancreatic cancer is characterized by late diagnosis, therapy resistance, and poor prognosis, necessitating the exploration of early carcinogenesis and prevention methods. Preclinical mouse models have evolved from cell line-based to human tumor tissue- or organoid-derived xenografts, now to humanized mouse models and genetically engineered mouse models (GEMMs). GEMMs, primarily driven by oncogenic Kras mutations and tumor suppressor gene alterations, offer a realistic platform for investigating pancreatic cancer initiation, progression, and metastasis. The incorporation of inducible somatic mutations and CRISPR-Cas9 screening methods has expanded their utility. To better recapitulate tumor initiation triggered by inflammatory cues, common pancreatic risk factors are being integrated into model designs. This approach aims to decipher the role of environmental factors as secondary or parallel triggers of tumor initiation alongside oncogenic burdens. Emerging models exploring pancreatitis, obesity, diabetes, and other risk factors offer significant translational potential. This review describes current mouse models for studying pancreatic carcinogenesis, their combination with inflammatory factors, and their utility in evaluating pathogenesis, providing guidance for selecting the most suitable models for pancreatic cancer research.<\/jats:p>","DOI":"10.3390\/cancers17101676","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T09:58:27Z","timestamp":1747303107000},"page":"1676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Genes to Environment: Elucidating Pancreatic Carcinogenesis Through Genetically Engineered and Risk Factor-Integrated Mouse Models"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-7871","authenticated-orcid":false,"given":"Bin","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine IV, Heidelberg University Hospital, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Kristin","family":"Fritsche","sequence":"additional","affiliation":[{"name":"Institute of Anatomy and Cell Biology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"},{"name":"Institute of Anatomy, Leipzig University, 04103 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Hau\u00dfner","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvi Vikrant","family":"Inamdar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Laumen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-4465","authenticated-orcid":false,"given":"Michael","family":"Boettcher","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-5394","authenticated-orcid":false,"given":"Martin","family":"Gericke","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, Leipzig University, 04103 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-5600","authenticated-orcid":false,"given":"Patrick","family":"Michl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Heidelberg University Hospital, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4513-0506","authenticated-orcid":false,"given":"Jonas","family":"Rosendahl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","article-title":"The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"ref_4","first-page":"141","article-title":"Epidemiology and risk factors of pancreatic cancer","volume":"89","author":"Capasso","year":"2018","journal-title":"Acta Biomed."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: A review and meta-analysis","volume":"393","author":"Iodice","year":"2008","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wang, Y.-T., Gou, Y.-W., Jin, W.-W., Xiao, M., and Fang, H.-Y. (2016). Association between alcohol intake and the risk of pancreatic cancer: A dose\u2013response meta-analysis of cohort studies. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2241-1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00463","DOI":"10.14309\/ctg.0000000000000463","article-title":"Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases with Duration of Disease: A Systematic Review and Meta-analysis","volume":"13","author":"Gandhi","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15330338231164875","DOI":"10.1177\/15330338231164875","article-title":"Pancreatitis and Pancreatic Cancer Risk","volume":"22","author":"Ma","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjc.6601140","article-title":"A meta-analysis of obesity and the risk of pancreatic cancer","volume":"89","author":"Sweetland","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2020.11.040","article-title":"A review of lifestyle and environment risk factors for pancreatic cancer","volume":"145","author":"Zanini","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3748\/wjg.v19.i26.4234","article-title":"Hepatitis B or C viral infection and risk of pancreatic cancer: A meta-analysis of observational studies","volume":"19","author":"Xu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Grigorescu, R.R., Husar-Sburlan, I.A., and Gheorghe, C. (2024). Pancreatic Cancer: A Review of Risk Factors. Life, 14.","DOI":"10.3390\/life14080980"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Marstrand-Dauc\u00e9, L., Lorenzo, D., Chassac, A., Nicole, P., Couvelard, A., and Haumaitre, C. (2023). Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24129946"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/ijbs.14995","article-title":"Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer","volume":"12","author":"Guo","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","article-title":"Mutations in key driver genes of pancreatic cancer: Molecularly targeted therapies and other clinical implications","volume":"42","author":"Hu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mpdhp.2011.10.012","article-title":"Reporting precursors to invasive pancreatic cancer: Pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm","volume":"18","author":"Hruban","year":"2012","journal-title":"Diagn. Histopathol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mallya, K., Gautam, S.K., Aithal, A., Batra, S.K., and Jain, M. (2021). Modeling pancreatic cancer in mice for experimental therapeutics. Biochim. Biophys. Acta Rev. Cancer, 1876.","DOI":"10.1016\/j.bbcan.2021.188554"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Fernandez, J.L., \u00c5rbogen, S., Sadeghinia, M.J., Haram, M., Snipstad, S., Torp, S.H., Einen, C., M\u00fchlenpfordt, M., Maardalen, M., and Vikedal, K. (2023). A Comparative Analysis of Orthotopic and Subcutaneous Pancreatic Tumour Models: Tumour Microenvironment and Drug Delivery. Cancers, 15.","DOI":"10.3390\/cancers15225415"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jncc.2022.10.001","article-title":"Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models","volume":"2","author":"Wang","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/apc.2020.03.03","article-title":"Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma","volume":"3","author":"He","year":"2020","journal-title":"Ann. Pancreat. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050520-100526","article-title":"Humanized Mouse Models to Evaluate Cancer Immunotherapeutics","volume":"5","author":"Sedlik","year":"2021","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_23","first-page":"717","article-title":"Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL\/6 mice","volume":"44","author":"Corbett","year":"1984","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Torres, M.P., Rachagani, S., Souchek, J.J., Mallya, K., Johansson, S.L., and Batra, S.K. (2013). Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080580"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0b013e31827ab4c4","article-title":"Genetically engineered mouse models of pancreatic cancer","volume":"18","author":"Westphalen","year":"2012","journal-title":"Cancer J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.acr.2023.02.002","article-title":"Chapter Three\u2014In vivo models of pancreatic ductal adenocarcinoma","volume":"Volume 159","author":"Emdad","year":"2023","journal-title":"Advances in Cancer Research"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.2821617","article-title":"Pancreatic Neoplasia Induced by SV40 T-Antigen Expression in Acinar Cells of Transgenic Mice","volume":"238","author":"Ornitz","year":"1987","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0092-8674(87)90710-0","article-title":"Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice","volume":"48","author":"Quaife","year":"1987","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.88.1.93","article-title":"Pancreatic tumor pathogenesis reflects the causative genetic lesion","volume":"88","author":"Sandgren","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(90)90075-P","article-title":"Overexpression of TGF\u03b1 in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast","volume":"61","author":"Sandgren","year":"1990","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","article-title":"Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia","volume":"142","author":"Kanda","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hirth, M., Xie, Y., H\u00f6per, C., Prats, A., Hackert, T., Ebert, M.P., and Kuner, R. (2022). Genetic Mouse Models to Study Pancreatic Cancer-Induced Pain and Reduction in Well-Being. Cells, 11.","DOI":"10.3390\/cells11172634"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1053\/j.gastro.2011.05.041","article-title":"Deletion of Rb Accelerates Pancreatic Carcinogenesis by Oncogenic Kras and Impairs Senescence in Premalignant Lesions","volume":"141","author":"Gore","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2007.01.017","article-title":"KrasG12D and Smad4\/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas","volume":"11","author":"Izeradjene","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2015.09.013","article-title":"Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice with Activated KRAS","volume":"150","author":"Qiu","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Costanza, B., Umelo, I.A., Bellier, J., Castronovo, V., and Turtoi, A. (2017). Stromal Modulators of TGF-\u03b2 in Cancer. J. Clin. Med., 6.","DOI":"10.3390\/jcm6010007"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2018.08.006","article-title":"GNAS(R201C) Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling","volume":"155","author":"Ideno","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/onc.2015.294","article-title":"GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm","volume":"35","author":"Taki","year":"2016","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival","volume":"25","author":"Carstens","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3748\/wjg.v27.i18.2105","article-title":"Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects","volume":"27","author":"Polani","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1242\/dmm.021055","article-title":"GEMMs as preclinical models for testing pancreatic cancer therapies","volume":"8","author":"Gopinathan","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2017-314426","article-title":"Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma","volume":"68","author":"Lee","year":"2019","journal-title":"Gut"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling Human Cancer-induced Cachexia","volume":"28","author":"Talbert","year":"2019","journal-title":"Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1101\/gad.264861.115","article-title":"Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR\/Cas9-mediated somatic genome editing","volume":"29","author":"Chiou","year":"2015","journal-title":"Genes Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/nm.3646","article-title":"A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer","volume":"20","author":"Seidler","year":"2014","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"Collins","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.15190\/d.2016.5","article-title":"A Versatile Gene Delivery System for Efficient and Tumor Specific Gene Manipulation in vivo","volume":"4","author":"Wang","year":"2016","journal-title":"Discoveries"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2013.09.044","article-title":"Activated Wnt Signaling in Stroma Contributes to Development of Pancreatic Mucinous Cystic Neoplasms","volume":"146","author":"Sano","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41596-021-00677-0","article-title":"CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver","volume":"17","author":"Kaltenbacher","year":"2022","journal-title":"Nat. Protoc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41587-020-0490-7","article-title":"Design and analysis of CRISPR\u2013Cas experiments","volume":"38","author":"Hanna","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Oktriani, R., Pirona, A.C., Kalm\u00e1r, L., Rahadian, A.S., Miao, B., Bauer, A.S., Hoheisel, J.D., Boettcher, M., and Du, H. (2024). Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma. Cancers, 16.","DOI":"10.3390\/cancers16213684"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","article-title":"Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41596-022-00700-y","article-title":"Tutorial: Design and execution of CRISPR in vivo screens","volume":"17","author":"Braun","year":"2022","journal-title":"Nat. Protoc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s43018-020-0040-8","article-title":"Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics","volume":"1","author":"Hulton","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2020.10.017","article-title":"Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","article-title":"In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer","volume":"23","author":"Dubrot","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-018-06676-2","article-title":"CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response","volume":"9","author":"Szlachta","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1038\/ncomms10770","article-title":"Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR\/Cas9 delivery in mice","volume":"7","author":"Maresch","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1038\/s41467-024-49450-3","article-title":"In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer","volume":"15","author":"Martinez","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41374-020-00494-1","article-title":"Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas","volume":"101","author":"Beato","year":"2021","journal-title":"Lab. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.stem.2021.11.001","article-title":"Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis","volume":"29","author":"Ungricht","year":"2022","journal-title":"Cell Stem Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.stem.2020.04.003","article-title":"Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids","volume":"26","author":"Michels","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2020.02.007","article-title":"Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-\u03b2 Resistance","volume":"26","author":"Ringel","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1158\/0008-5472.CAN-21-2519","article-title":"Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing","volume":"82","author":"Sayed","year":"2022","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: A widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41587-020-0600-6","article-title":"Optimization of AsCas12a for combinatorial genetic screens in human cells","volume":"39","author":"DeWeirdt","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","article-title":"Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group","volume":"328","author":"Lowenfels","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kim, H.S., Gweon, T.-G., Park, S.H., Kim, T.H., Kim, C.W., and Chang, J.H. (2023). Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: Defining the optimal subgroup for surveillance. Sci. Rep., 13.","DOI":"10.1038\/s41598-022-26411-8"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2018.02.011","article-title":"Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark","volume":"154","author":"Mortensen","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Park, S.M., Kim, K.B., Han, J.-H., Kim, N., Kang, T.U., Swan, H., and Kim, H.J. (2023). Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: A population-based cohort study. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-45382-y"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.51.6.849","article-title":"Risk of pancreatic adenocarcinoma in chronic pancreatitis","volume":"51","author":"Malka","year":"2002","journal-title":"Gut"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.surg.2012.08.005","article-title":"Surgery for chronic pancreatitis decreases the risk for pancreatic cancer: A multicenter retrospective analysis","volume":"153","author":"Ueda","year":"2013","journal-title":"Surgery"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archinternmed.2009.125","article-title":"Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis","volume":"169","author":"Yadav","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1159\/000327212","article-title":"Alcohol abuse, endoplasmic reticulum stress and pancreatitis","volume":"28","author":"Pandol","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0016-5085(98)70097-6","article-title":"Pancreatic duct obstruction is an aggravating factor in the canine model of chronic alcoholic pancreatitis","volume":"115","author":"Tanaka","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.51.1.1","article-title":"Autoimmune related pancreatitis","volume":"51","author":"Okazaki","year":"2002","journal-title":"Gut"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1096-141","article-title":"Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene","volume":"14","author":"Whitcomb","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/76088","article-title":"Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis","volume":"25","author":"Witt","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.2730","article-title":"Variants in CPA1 are strongly associated with early onset chronic pancreatitis","volume":"45","author":"Witt","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1053\/gast.1997.v113.pm9322498","article-title":"Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis","volume":"113","author":"Gorry","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2009.186817","article-title":"The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families","volume":"59","author":"Grocock","year":"2010","journal-title":"Gut"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(99)70543-3","article-title":"A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis","volume":"117","author":"Witt","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.20148","article-title":"Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl","volume":"25","author":"Teich","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.2000.3797","article-title":"Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen","volume":"278","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1053\/j.gastro.2006.09.049","article-title":"A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen","volume":"131","author":"Archer","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1038\/cddis.2014.120","article-title":"Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death","volume":"5","author":"Athwal","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/s41467-018-07347-y","article-title":"A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation","volume":"9","author":"Geisz","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2022.06.001","article-title":"Rate of Autoactivation Determines Pancreatitis Phenotype in Trypsinogen Mutant Mice","volume":"163","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng.2007.44","article-title":"Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis","volume":"40","author":"Rosendahl","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00439-007-0459-3","article-title":"Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis","volume":"123","author":"Masson","year":"2008","journal-title":"Hum. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2018.06.041","article-title":"Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice","volume":"155","author":"Hegyi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.bi.49.070180.003113","article-title":"Protein inhibitors of proteinases","volume":"49","author":"Laskowski","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00431.2009","article-title":"Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype","volume":"298","author":"Romac","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.gastro.2005.05.057","article-title":"Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice","volume":"129","author":"Ohmuraya","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"101361","DOI":"10.1016\/j.jcmgh.2024.05.009","article-title":"Heterozygous Spink1 Deficiency Promotes Trypsin-dependent Chronic Pancreatitis in Mice","volume":"18","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0016-5085(81)90007-X","article-title":"Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing\/sodium dodecyl sulfate gel electrophoresis","volume":"80","author":"Scheele","year":"1981","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1074\/jbc.M110.187369","article-title":"Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2","volume":"286","author":"Szmola","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/gutjnl-2018-315994","article-title":"Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice","volume":"68","author":"Hegyi","year":"2019","journal-title":"Gut"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","article-title":"Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice","volume":"11","author":"Guerra","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What We Talk About When We Talk About Fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zatterale, F., Longo, M., Naderi, J., Raciti, G.A., Desiderio, A., Miele, C., and Beguinot, F. (2020). Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01607"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","article-title":"The obese adipose tissue microenvironment in cancer development and progression","volume":"15","author":"Quail","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5\u00b724 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/1078-0432.CCR-14-2385","article-title":"Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN)","volume":"21","author":"Rebours","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/01635581.2024.2361964","article-title":"The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications","volume":"76","author":"Rabbani","year":"2024","journal-title":"Nutr. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e202302228","DOI":"10.26508\/lsa.202302228","article-title":"Decoding the obesity\u2013cancer connection: Lessons from preclinical models of pancreatic adenocarcinoma","volume":"6","author":"Ruiz","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2013.08.018","article-title":"A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice","volume":"145","author":"Philip","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5455\/javar.2020.g399","article-title":"A systematic review on different models of inducing obesity in animals: Advantages and limitations","volume":"7","author":"Suleiman","year":"2020","journal-title":"J. Adv. Vet. Anim. Res."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Kfoury, S., Michl, P., and Roth, L. (2022). Modeling Obesity-Driven Pancreatic Carcinogenesis-A Review of Current In Vivo and In Vitro Models of Obesity and Pancreatic Carcinogenesis. Cells, 11.","DOI":"10.3390\/cells11193170"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0471141755.ph0561s58","article-title":"Overview of animal models of obesity","volume":"58","author":"Lutz","year":"2012","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Wu, S.-C., and Lin, C.-H. (2023). Direct Adeno-associated Viruses Injection of Murine Adipose Tissue. Bio-Protocol, 13.","DOI":"10.21769\/BioProtoc.4674"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Singh, R., Gholipourmalekabadi, M., and Shafikhani, S.H. (2024). Animal models for type 1 and type 2 diabetes: Advantages and limitations. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1359685"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cell.2020.03.062","article-title":"Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma","volume":"181","author":"Chung","year":"2020","journal-title":"Cell"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: New mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1078-0432.CCR-12-0930","article-title":"Molecular pathways: Adiponectin and leptin signaling in cancer","volume":"19","author":"Vansaun","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu. Rev. Physiol."},{"key":"ref_133","first-page":"945","article-title":"Leptin receptor mediates the proliferation and glucose metabolism of pancreatic cancer cells via AKT pathway activation","volume":"21","author":"Xu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Mendonsa, A.M., Chalfant, M.C., Gorden, L.D., and Vansaun, M.N. (2015). Modulation of the leptin receptor mediates tumor growth and migration of pancreatic cancer cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126686"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"16120","DOI":"10.18632\/oncotarget.3878","article-title":"Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"E573","DOI":"10.1152\/ajpendo.00460.2014","article-title":"High-fat diet-induced \u03b2-cell proliferation occurs prior to insulin resistance in C57Bl\/6J male mice","volume":"308","author":"Mosser","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"E738","DOI":"10.1152\/ajpendo.00199.2002","article-title":"Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice","volume":"283","author":"Ahren","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/db07-1615","article-title":"Glucose metabolism in vivo in four commonly used inbred mouse strains","volume":"57","author":"Berglund","year":"2008","journal-title":"Diabetes"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00125-013-2913-1","article-title":"Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding","volume":"56","author":"Turner","year":"2013","journal-title":"Diabetologia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Chang, H.-H., Moro, A., Takakura, K., Su, H.-Y., Mo, A., Nakanishi, M., Waldron, R.T., French, S.W., Dawson, D.W., and Hines, O.J. (2017). Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184455"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Ead, A.S., Wirkus, J., Matsukuma, K., and Mackenzie, G.G. (2024). A high-fat diet induces changes in mesenteric adipose tissue accelerating early-stage pancreatic carcinogenesis in mice. J. Nutr. Biochem., 131.","DOI":"10.1016\/j.jnutbio.2024.109690"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"18280","DOI":"10.18632\/oncotarget.15430","article-title":"Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells","volume":"8","author":"Okumura","year":"2017","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1940-6207.CAPR-13-0065","article-title":"High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model","volume":"6","author":"Dawson","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1053\/j.gastro.2019.07.030","article-title":"Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41392-023-01376-w","article-title":"Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: A comprehensive and systematic review","volume":"8","author":"Ruze","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Zhu, L., Ji, J., Ma, J., Wang, D., Liu, M., Du, J.X., Chen, R., Hou, W., Abbruzzese, J.L., and Logsdon, C.D. (2022). Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14112723"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gt.2014.38","article-title":"Targeting adipose tissue via systemic gene therapy","volume":"21","author":"Hinkle","year":"2014","journal-title":"Gene Ther."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Uhrig-Schmidt, S., Geiger, M., Luippold, G., Birk, G., Mennerich, D., Neubauer, H., Grimm, D., Wolfrum, C., and Kreuz, S. (2014). Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0116288"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.omtm.2020.09.009","article-title":"Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors","volume":"19","author":"Bates","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Mallya, K., Haridas, D., Seshacharyulu, P., Pothuraju, R., Junker, W.M., Krishn, S.R., Muniyan, S., Vengoji, R., Batra, S.K., and Rachagani, S. (2020). Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biol. Open, 9.","DOI":"10.1242\/bio.052878"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Lupo, F., Piro, G., Torroni, L., Delfino, P., Trovato, R., Rusev, B., Fiore, A., Filippini, D., Sanctis, F.d., and Manfredi, M. (2020). Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo. Front. Cell Dev. Biology, 8.","DOI":"10.3389\/fcell.2020.00308"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1055-9965.EPI-22-0951","article-title":"The Relationship between Diabetes Mellitus and Pancreatic Cancer\u2014Diabetes Mellitus as a Red Flag for Pancreatic Cancer","volume":"32","author":"Popovic","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Duvilli\u00e9, B., Kourdoughli, R., Druillennec, S., Eych\u00e8ne, A., and Pouponnot, C. (2020). Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.563267"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/ijbs.15001","article-title":"Pancreatic Cancer Genetics","volume":"12","author":"Amundadottir","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e102808","DOI":"10.15252\/embj.2019102808","article-title":"HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer","volume":"39","author":"Kalisz","year":"2020","journal-title":"EMBO J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/s41467-018-03943-0","article-title":"LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus","volume":"9","author":"Lorenzo","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/gutjnl-2012-304381","article-title":"Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis","volume":"63","author":"Flandez","year":"2014","journal-title":"Gut"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature25751","article-title":"Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas","volume":"554","author":"Cobo","year":"2018","journal-title":"Nature"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s42255-020-00315-1","article-title":"KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth","volume":"2","author":"Raho","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10552-010-9686-3","article-title":"Diabetes and risk of pancreatic cancer: A pooled analysis of three large case\u2013control studies","volume":"22","author":"Li","year":"2011","journal-title":"Cancer Causes Control"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.annepidem.2009.11.010","article-title":"Past Medical History and Pancreatic Cancer Risk: Results from a Multicenter Case-Control Study","volume":"20","author":"Maisonneuve","year":"2010","journal-title":"Ann. Epidemiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-016-3884-9","article-title":"Cancer incidence in persons with type 1 diabetes: A five-country study of 9,000 cancers in type 1 diabetic individuals","volume":"59","author":"Carstensen","year":"2016","journal-title":"Diabetologia"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"g7371","DOI":"10.1136\/bmj.g7371","article-title":"Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis","volume":"349","author":"Liao","year":"2015","journal-title":"BMJ"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13046-020-01665-0","article-title":"Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras(G12D\/+) mice","volume":"39","author":"Menini","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and Cancer: The Role of Dysfunctional Adipose Tissue","volume":"18","author":"Visseren","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Xu, T., Xu, X., Liu, P.-C., Mao, H., and Ju, S. (2020). Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.563527"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","article-title":"Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic Therapies Affect Risk of Pancreatic Cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-017-0701-0","article-title":"Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer","volume":"16","author":"Chen","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2017.5586","article-title":"Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis","volume":"13","author":"Tan","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e201900573","DOI":"10.26508\/lsa.201900573","article-title":"Pancreatic cancer triggers diabetes through TGF-\u03b2\u2013mediated selective depletion of islet \u03b2-cells","volume":"3","author":"Parajuli","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3892\/ol.2017.5606","article-title":"Effect of cigarette smoke exposure and mutant Kras overexpression on pancreatic cell proliferation","volume":"13","author":"Glauert","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/jco.2014.32.3_suppl.229","article-title":"Mouse models of pancreatic cancer induced by chronic pancreatitis and smoking","volume":"32","author":"Edderkaoui","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.gastro.2018.05.041","article-title":"Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1","volume":"155","author":"Nimmakayala","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1053\/j.gastro.2014.08.002","article-title":"Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice","volume":"147","author":"Hermann","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/carcin\/bgs186","article-title":"Interplay between Smoking-induced Genotoxicity and Altered Signaling in Pancreatic Carcinogenesis","volume":"33","author":"Momi","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MPA.0000000000001550","article-title":"The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis","volume":"49","author":"Weissman","year":"2020","journal-title":"Pancreas"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"G265","DOI":"10.1152\/ajpgi.00218.2019","article-title":"Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras","volume":"318","author":"Asahina","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"106841","DOI":"10.1016\/j.isci.2023.106841","article-title":"Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer","volume":"26","author":"Kaune","year":"2023","journal-title":"iScience"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pan.2023.07.008","article-title":"Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma","volume":"23","author":"Pfisterer","year":"2023","journal-title":"Pancreatology"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2012-303006","article-title":"Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study","volume":"62","author":"Michaud","year":"2013","journal-title":"Gut"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gutjnl-2023-330941","article-title":"Oral bacteria accelerate pancreatic cancer development in mice","volume":"73","author":"Saba","year":"2024","journal-title":"Gut"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","article-title":"Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models","volume":"39","author":"Thomas","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10555-022-10022-w","article-title":"Connecting the Human Microbiome and Pancreatic Cancer","volume":"41","author":"Sexton","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PPO.0000000000000647","article-title":"The Gut Microbiome and Pancreatic Cancer Development and Treatment","volume":"29","author":"Attebury","year":"2023","journal-title":"Cancer J."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Liot, S., El Kholti, N., Balas, J., Genestier, L., Verrier, B., Valcourt, U., and Lambert, E. (2021). Development of thymic tumor in [LSL:KrasG12D.; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-94566-x"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:33:26Z","timestamp":1760031206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":189,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cancers17101676"],"URL":"https:\/\/doi.org\/10.3390\/cancers17101676","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}